title: GPIaIIa as a candidate target for anti-platelet autoantibody occurring during valproate therapy and associated with peroperative bleeding.
authors.forename: V
authors.initials: V
authors.lastname: Proulle
authors.forename: P
authors.initials: P
authors.lastname: Masnou
authors.forename: J
authors.initials: J
authors.lastname: Cartron
authors.forename: C
authors.initials: C
authors.lastname: Kaplan
authors.forename: N
authors.initials: N
authors.lastname: Ajzenberg
authors.forename: G
authors.initials: G
authors.lastname: Tchernia
authors.forename: M
authors.initials: M
authors.lastname: Dreyfus
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001254:Astrocytoma / Q000188:drug therapy; D001323:Autoantibodies / Q000276:immunology*; D001792:Blood Platelets / Q000276:immunology*; D001932:Brain Neoplasms / Q000188:drug therapy; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced* / Q000276:immunology*; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced*; D019038:Platelet Glycoprotein GPIb-IX Complex / Q000276:immunology; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D001323:Autoantibodies; D019038:Platelet Glycoprotein GPIb-IX Complex; D014635:Valproic Acid